Fernandes Natasha
Known title: Chief Financial Officer & EVPCIK: 0001928296
Associated companies
Transaction History
| IMAX | ▼ Sell | Open Market | 20,000 | $1.1M | 8/24/2026 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 10,974 | $448K | 3/7/2026 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 17,070 | $696K | 3/7/2026 | View on chart |
| IMAX | ▲ Buy | Grant | 10,072 | $0 | 3/7/2026 | View on chart |
| IMAX | ▲ Buy | Grant | 21,815 | $0 | 3/7/2026 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 6,927 | $0 | 3/7/2026 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 7,903 | $0 | 3/7/2026 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 5,666 | $0 | 3/7/2026 | View on chart |
| IMAX | ▼ Sell | Other | 2,652 | $60K | 11/24/2025 | View on chart |
| IMAX | ▼ Sell | Open Market | 2,652 | $96K | 11/24/2025 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 7,422 | $0 | 3/7/2025 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 6,925 | $0 | 3/7/2025 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 7,903 | $0 | 3/7/2025 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 11,911 | $301K | 3/7/2025 | View on chart |
| IMAX | ▲ Buy | Grant | 12,988 | $0 | 3/7/2025 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 6,953 | $176K | 3/7/2025 | View on chart |
| IMAX | ▼ Sell | Open Market | 2,957 | $75K | 12/9/2024 | View on chart |
| IMAX | ▼ Sell | Other | 2,957 | $62K | 12/9/2024 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 8,147 | $137K | 3/7/2024 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 799 | $13K | 3/7/2024 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 871 | $0 | 3/7/2024 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 6,925 | $0 | 3/7/2024 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 7,422 | $0 | 3/7/2024 | View on chart |
| IMAX | ▲ Buy | Grant | 1,492 | $0 | 3/7/2024 | View on chart |
| IMAX | ▲ Buy | Grant | 2,210 | $0 | 3/7/2023 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 1,184 | $22K | 3/7/2023 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 1,264 | $0 | 3/7/2023 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 844 | $0 | 3/7/2023 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 7,422 | $0 | 3/7/2023 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 5,102 | $94K | 3/7/2023 | View on chart |
| IMAX | ▲ Buy | Option Exercise | 751 | $0 | 12/1/2022 | View on chart |
| IMAX | ▼ Sell | Tax Withholding | 403 | $7K | 12/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
IMAX Faces Disney Competition Amid Record Re-Release
IMAX stock is navigating a period where Disney is pushing its own big-screen format, creating competitive pressure. However, Wedbush analysts state there is no immediate threat from a potential Disney coalition. Meanwhile, the record-breaking re-release of 'The Odyssey' continues to support the company's investment case, even as the stock trades near its support level.
IMAX Faces Disney Competition Amid Record Re-Release. IMAX stock is navigating a period where Disney is pushing its own big-screen format, creating competitive pressure. However, Wedbush analysts state there is no immediate threat from a potential Disney coalition. Meanwhile, the record-breaking re-release of 'The Odyssey' continues to support the company's investment case, even as the stock trades near its support level.